Get started
Author

Christopher M. Longshaw

Observed names: C. Longshaw, C. M. Longshaw, C.M. Longshaw, Chris Longshaw, Chris M Longshaw, Chris M. Longshaw, Christopher Longshaw, Christopher M Longshaw
Institution: Shionogi (Japan)
ORCID: 0000-0002-5586-7256
Observed ORCID: 0000-0002-5586-7256
OpenAlex ID: A5016916593
Underdiagnosis of Clostridium difficile across Europe: the European, multicentre, prospective, biannual, point-prevalence study of Clostridium difficile infection in hospitalised patients with diarrhoea (EUCLID)
2014 · Kerrie A Davies, Christopher M Longshaw, et al. · The Lancet Infectious Diseases · 365
Pan-European longitudinal surveillance of antibiotic resistance among prevalent Clostridium difficile ribotypes
2014 · J. Freeman, J. Vernon, et al. · Clinical Microbiology and Infection · 289
PDF
Extended-pulsed fidaxomicin versus vancomycin for Clostridium difficile infection in patients 60 years and older (EXTEND): a randomised, controlled, open-label, phase 3b/4 trial
2017 · Benoit Guery, Francesco Menichetti, et al. · The Lancet Infectious Diseases · 237
PDF
Diversity of Clostridium difficile PCR ribotypes in Europe: results from the European, multicentre, prospective, biannual, point-prevalence study of Clostridium difficile infection in hospitalised patients with diarrhoea (EUCLID), 2012 and 2013
2016 · Kerrie A Davies, Helen Ashwin, et al. · Eurosurveillance · 194
Risk factors for carbapenem-resistant Gram-negative bacterial infections: a systematic review
2020 · Zaira R. Palacios-Baena, Maddalena Giannella, et al. · Clinical Microbiology and Infection · 171
Systematic review on estimated rates of nephrotoxicity and neurotoxicity in patients treated with polymyxins
2021 · Florian Wagenlehner, Ersilia Lucenteforte, et al. · Clinical Microbiology and Infection · 160
PDF
The ClosER study: results from a three-year pan-European longitudinal surveillance of antibiotic resistance among prevalent Clostridium difficile ribotypes, 2011–2014
2017 · J. Freeman, J. Vernon, et al. · Clinical Microbiology and Infection · 143
Unsaturated fatty acids are inhibitors of bacterial conjugation
2005 · Raul Fernandez-Lopez, Cristina Machón, et al. · Microbiology · 140
PDF
A Systematic Review of the Effect of Delayed Appropriate Antibiotic Treatment on the Outcomes of Patients With Severe Bacterial Infections
2020 · Evan J. Zasowski, Matteo Bassetti, et al. · CHEST Journal · 125
PDF
Systematic review of the impact of appropriate versus inappropriate initial antibiotic therapy on outcomes of patients with severe bacterial infections
2020 · Matteo Bassetti, Jordi Rello, et al. · International Journal of Antimicrobial Agents · 120
Is the GehD Lipase from Staphylococcus epidermidis a Collagen Binding Adhesin?
2002 · M. Gabriela Bowden, Livia Visai, et al. · Journal of Biological Chemistry · 116
PDF
Quality indicators assessing antibiotic use in the outpatient setting: a systematic review followed by an international multidisciplinary consensus procedure
2018 · Marion Le Maréchal, Gianpiero Tebano, et al. · Journal of Antimicrobial Chemotherapy · 112
PDF
Antibiotic research and development: business as usual?
2015 · S. Harbarth, U. Theuretzbacher, et al. · Journal of Antimicrobial Chemotherapy · 85
PDF
Two Distinct Patterns of Clostridium difficile Diversity Across Europe Indicating Contrasting Routes of Spread
2018 · David W Eyre, Kerrie A Davies, et al. · Clinical Infectious Diseases · 84
PDF
Identification of a second lipase gene, gehD, in Staphylococcus epidermidis: comparison of sequence with those of other staphylococcal lipases The GenBank accession number for the nucleotide sequence determined in this work is AF090142.
2000 · Christopher M. Longshaw, Angela M. Farrell, et al. · Microbiology · 83
Cefiderocol: EUCAST criteria for disc diffusion and broth microdilution for antimicrobial susceptibility testing
2022 · Erika Matuschek, Christopher Longshaw, et al. · Journal of Antimicrobial Chemotherapy · 79
In vitroactivity of the siderophore cephalosporin, cefiderocol, against molecularly characterized, carbapenem-non-susceptible Gram-negative bacteria from Europe
2020 · Christopher Longshaw, Davide Manissero, et al. · JAC-Antimicrobial Resistance · 78
PDF
Kytococcus sedentarius, the organism associated with pitted keratolysis, produces two keratin-degrading enzymes
2002 · C.M. Longshaw, J.D. Wright, et al. · Journal of Applied Microbiology · 76
In Vitro Activity of Telavancin in Combination with Colistin versus Gram-Negative Bacterial Pathogens
2012 · Michael Hornsey, Christopher Longshaw, et al. · Antimicrobial Agents and Chemotherapy · 61
Application of the hollow fibre infection model (HFIM) in antimicrobial development: a systematic review and recommendations of reporting
2021 · Zahra Sadouki, Timothy D. McHugh, et al. · Journal of Antimicrobial Chemotherapy · 57
PDF
In vitro activity of the novel siderophore cephalosporin, cefiderocol, in Gram-negative pathogens in Europe by site of infection
2021 · Francisco Javier Candel, Anne Santerre Henriksen, et al. · Clinical Microbiology and Infection · 54
Successful treatment of simulated Clostridium difficile infection in a human gut model by fidaxomicin first line and after vancomycin or metronidazole failure
2013 · C. H. Chilton, G. S. Crowther, et al. · Journal of Antimicrobial Chemotherapy · 51
In vivo efficacy of telavancin/colistin combination therapy in a Galleria mellonella model of Acinetobacter baumannii infection
2013 · Michael Hornsey, Lynette Phee, et al. · International Journal of Antimicrobial Agents · 47
Metrics to assess the quantity of antibiotic use in the outpatient setting: a systematic review followed by an international multidisciplinary consensus procedure
2018 · Ann Versporten, Inge C Gyssens, et al. · Journal of Antimicrobial Chemotherapy · 46
PDF
Replacement of Enterococcus faecalis by Enterococcus faecium as the predominant enterococcus in UK bacteraemias
2021 · Carolyne Horner, Shazad Mushtaq, et al. · JAC-Antimicrobial Resistance · 45
PDF
Works count: 108
Citation count: 3,632
H-index: 31
I10-index: 47
Year
Topic
Type